UNC Lineberger News

Drug That Inhibits Vascular Development Does Not Help Colon Cancer Survival

In a study published this month in the Journal of Clinical Oncology, the results of a clinical trial of the drug bevacizumab to treat colon cancer in combination with the standard therapy found that the drug did not significantly increase disease-free survival in patients with stage II and stage III colon cancer.

Drug That Inhibits Vascular Development Does Not Help Colon Cancer Survival - Read More…

Sharpless Featured in Current Issue of endeavors

The article "How Old Are You, Really?" written by Mark Derewicz and published in the Fall 2010 issue of Endeavors magazine features UNC Lineberger member Ned Sharpless, MD. Dr. Sharpless is an associate professor of medicine and genetics and associate director for translational research at UNC Lineberger.

Sharpless Featured in Current Issue of endeavors - Read More…